» Articles » PMID: 22457593

Silver Nanoparticles Modify VEGF Signaling Pathway and Mucus Hypersecretion in Allergic Airway Inflammation

Overview
Publisher Dove Medical Press
Specialty Biotechnology
Date 2012 Mar 30
PMID 22457593
Citations 34
Authors
Affiliations
Soon will be listed here.
Abstract

The anti-inflammatory action of silver nanoparticles (NPs) has been reported in a murine model of asthma in a previous study. But more specific mechanisms of silver NPs in an attenuation of allergic airway inflammation have not yet been established. Vascular and mucous changes are believed to contribute largely in pathophysiology in asthma. Among various factors related to vascular changes, vascular endothelial growth factor (VEGF) plays a pivotal role in vascular changes in asthma. Mucin proteins MUC5AC and MUC5B have been implicated as markers of goblet cell metaplasia in lung pathologies. The aim of this study was to investigate the effects of silver NPs on VEGF signaling pathways and mucus hypersecretion. Ovalbumin (OVA)-inhaled female BALBc mice were used to evaluate the role of silver NPs and the related molecular mechanisms in allergic airway disease. In this study, with an OVA-induced murine model of allergic airway disease, it was found that the increased levels of hypoxia-inducible factor (HIF)-1α, VEGF, phosphatidylinositol-3 kinase (PI3K) and phosphorylated-Akt levels, and mucous glycoprotein expression (Muc5ac) in lung tissues were substantially decreased by the administration of silver NPs. In summary, silver NPs substantially suppressed mucus hypersecretion and PI3K/HIF-1α/VEGF signaling pathway in an allergic airway inflammation.

Citing Articles

Nanotechnology-Based Therapeutics for Airway Inflammatory Diseases.

Cui L, Yang Y, Hao Y, Zhao H, Zhang Y, Wu T Clin Rev Allergy Immunol. 2025; 68(1):12.

PMID: 39928241 PMC: 11811441. DOI: 10.1007/s12016-024-09019-w.


Innovative approaches to asthma treatment: harnessing nanoparticle technology.

Goswami V, Sodhi K, Singh C Discov Nano. 2025; 20(1):21.

PMID: 39922940 PMC: 11807046. DOI: 10.1186/s11671-025-04211-z.


Anti-inflammatory coupled anti-angiogenic airway stent effectively suppresses tracheal in-stents restenosis.

Zhao Y, Liu Y, Shan J, Xu X, Zhang C, Liu Z J Nanobiotechnology. 2025; 23(1):59.

PMID: 39881307 PMC: 11776288. DOI: 10.1186/s12951-024-03087-y.


Histochemistry for Molecular Imaging in Nanomedicine.

Malatesta M Int J Mol Sci. 2024; 25(15).

PMID: 39125610 PMC: 11311594. DOI: 10.3390/ijms25158041.


Pioneering Topical Ointment Intervention for Unprecedented Antimicrobial and Diabetic Wound Management with Phenylpropanoids and Nano-Silver.

Nagaiah H, Periyakaruppan Murugesan P, Ravindra Rupali C, Shunmugiah K AAPS J. 2024; 26(4):67.

PMID: 38862870 DOI: 10.1208/s12248-024-00936-4.


References
1.
Wilhelm S, Adnane L, Newell P, Villanueva A, Llovet J, Lynch M . Preclinical overview of sorafenib, a multikinase inhibitor that targets both Raf and VEGF and PDGF receptor tyrosine kinase signaling. Mol Cancer Ther. 2008; 7(10):3129-40. DOI: 10.1158/1535-7163.MCT-08-0013. View

2.
Shao M, Nakanaga T, Nadel J . Cigarette smoke induces MUC5AC mucin overproduction via tumor necrosis factor-alpha-converting enzyme in human airway epithelial (NCI-H292) cells. Am J Physiol Lung Cell Mol Physiol. 2004; 287(2):L420-7. DOI: 10.1152/ajplung.00019.2004. View

3.
Cho J, Miller M, Baek K, Han J, Nayar J, Lee S . Inhibition of airway remodeling in IL-5-deficient mice. J Clin Invest. 2004; 113(4):551-60. PMC: 338264. DOI: 10.1172/JCI19133. View

4.
Park H, Kim K, Jang S, Park J, Cha H, Lee J . Attenuation of allergic airway inflammation and hyperresponsiveness in a murine model of asthma by silver nanoparticles. Int J Nanomedicine. 2010; 5:505-15. PMC: 2950409. DOI: 10.2147/ijn.s11664. View

5.
Laughner E, Taghavi P, Chiles K, Mahon P, Semenza G . HER2 (neu) signaling increases the rate of hypoxia-inducible factor 1alpha (HIF-1alpha) synthesis: novel mechanism for HIF-1-mediated vascular endothelial growth factor expression. Mol Cell Biol. 2001; 21(12):3995-4004. PMC: 87062. DOI: 10.1128/MCB.21.12.3995-4004.2001. View